Frontlight ResearchEarly access
Taking people in United StatesNo phase
Metabolomic Biomarkers of Myotonic Dystrophy
Key facts
- Who runs it
- Massachusetts General Hospital
- Where
- Boston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 64 people, planned
- Started
- 26 Oct 2026
- Expected to end
- Aug 2031
- Type of study
- Observational, 2 groups
- Record updated
- 3 November 2026
Who can take part
- Age
- 14 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Individuals with myotonic dystrophy
- Individuals without myotonic dystrophy
- Ages 14 years and older
Who cannot take part
- Use of anticoagulants within 60 days prior to blood draw
- State of immunosuppression
- Coagulopathy
Where in United States
- Massachusetts General HospitalBoston, United StatesContact: Tamkin Shahraki, MDTaking people
About the trial
What the trial wants to find out
Current methods of measuring the response to new treatments for muscular dystrophies involve the examination of small pieces of muscle tissue called biopsies. The investigators are interested in finding less invasive methods that reduce the need for muscle biopsies. The purpose of this research is to learn about the possibility of detecting and measuring the activity and severity of myotonic dystrophy by examining a urine sample and a blood sample, and performing muscle function testing. The information that is gathered from this study may help to evaluate, prevent, diagnose, treat, and improve the understanding of human myotonic dystrophy.
The 2 groups in the trial
- Myotonic dystrophy
- Unaffected
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 3 November 2026